Transderm scop and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Transderm scop (scopolamine) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include lymphocyte count decreased among females and hyperkalaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Transderm scop and Dilaudid. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Transderm scop?

Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 3,011 Transderm scop users. Check the latest studies of Transderm scop.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

On Jul, 04, 2026

70 people who take Transderm scop and Dilaudid together, and have interactions are studied.

Transderm scop and Dilaudid drug interactions.

What are the common drug interactions of Transderm Scop and Dilaudid, by gender? *:

female:

Lymphocyte count decreased
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Migraine (headache)
Sinusitis (inflammation of sinus)
Uterine haemorrhage (uterine bleeding)
Chest pain
Dry mouth
Nephrolithiasis (calculi in the kidneys)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Altered state of consciousness (altered state of mind)

male:

Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)
Blood lactic acid increased
Blood urea increased
Bone marrow failure
Bradycardia (abnormally slow heart action)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cytokine storm (over-protective immune response that can actually be fatal)
Haematuria (presence of blood in urine)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)

What are the common drug interactions of Transderm Scop and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pyrexia (fever)
Neutropenia (an abnormally low number of neutrophils)
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Blood creatinine increased
Blood lactic acid increased
Blood urea increased
Bone marrow failure
Bradycardia (abnormally slow heart action)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cytokine storm (over-protective immune response that can actually be fatal)

20-29:

Disability
Psychiatric symptom
Cough
Dry eye (lack of adequate tears)
Head discomfort
Sinusitis (inflammation of sinus)
Drug hypersensitivity
Cardiac arrest
Hyperglycaemia (high blood sugar)
Hepatobiliary disease (diseases affect the liver and/or biliary tract)

30-39:

Anaemia (lack of blood)
Hip arthroplasty
Hyperkalaemia (damage to or disease of the kidney)
Hypoxia (low oxygen in tissues)
Leukopenia (less number of white blood cells in blood)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Weight bearing difficulty (difficulty due to weight of thigh fat deposition)

40-49:

Abdominal distension
Abdominal pain
Device dislocation
Dysmenorrhoea (painful menstruation)
Fatigue (feeling of tiredness)
Lymphocyte count decreased
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Migraine (headache)
Uterine haemorrhage (uterine bleeding)
Altered state of consciousness (altered state of mind)

50-59:

Breast cancer
Anxiety
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Chronic kidney disease
Death
Disease progression
Drug dependence
Gastric atony (lack of muscle tone of stomach)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Impaired gastric emptying

60+:

Nausea (feeling of having an urge to vomit)
Chills (felling of cold)
Anxiety
Aphagia (inability or refusal to swallow)
Chest discomfort
Confusional state
Contusion (a type of hematoma of tissue in which capillaries)
Crying
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dry skin

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 23 people, 32.86%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 22.86%
Nausea (feeling of having an urge to vomit): 16 people, 22.86%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 12.86%
Constipation: 7 people, 10.00%
Depression: 7 people, 10.00%
Stress And Anxiety: 7 people, 10.00%
Nausea And Vomiting: 6 people, 8.57%
Indigestion: 6 people, 8.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Transderm scop and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously